CellMade’s focus on the use of primary human cells and stem cells for early inflammatory research and drug discovery is aimed at improving the safety and efficacy screening of new medicines. Drug R&D teams can use our cell products for target validation, biomarker and companion diagnostics discovery in addition to drug safety and efficacy screening in order to obtain reliable data that accurately reflects the human in vivo situation.
See our list of primary human cells for skin/dermal, ocular, cardiovascular, circulation and rheumatoid arthritis inflammation research.
We also provide CD34+ hematopoietic human stem cells, matched with PBMC-derived cell types from the same donor, for companion diagnostics, preclinical safety and efficacy assessments.
View our full human cell products catalogue to request pricing and information.
Can’t find what you’re looking for? Please call us to see if we can help you.